IL163984A0 - Method for producing crystals from active ingredients in medicaments, crystals obtained by said method, and use thereof in pharmaceutical formulation - Google Patents

Method for producing crystals from active ingredients in medicaments, crystals obtained by said method, and use thereof in pharmaceutical formulation

Info

Publication number
IL163984A0
IL163984A0 IL16398403A IL16398403A IL163984A0 IL 163984 A0 IL163984 A0 IL 163984A0 IL 16398403 A IL16398403 A IL 16398403A IL 16398403 A IL16398403 A IL 16398403A IL 163984 A0 IL163984 A0 IL 163984A0
Authority
IL
Israel
Prior art keywords
crystals
medicaments
active ingredients
pharmaceutical formulation
producing
Prior art date
Application number
IL16398403A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL163984A0 publication Critical patent/IL163984A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16398403A 2002-04-23 2003-04-22 Method for producing crystals from active ingredients in medicaments, crystals obtained by said method, and use thereof in pharmaceutical formulation IL163984A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10218106A DE10218106A1 (de) 2002-04-23 2002-04-23 Verfahren zum Herstellen von Kristallen von Arzneimittelwirkstoffen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
PCT/EP2003/004153 WO2003090721A2 (de) 2002-04-23 2003-04-22 Verfahren zur herstellung von kristallen von arzneimittelwirkstoffen und deren verwendung in pharmazeutischen formulierungen

Publications (1)

Publication Number Publication Date
IL163984A0 true IL163984A0 (en) 2005-12-18

Family

ID=29264786

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16398403A IL163984A0 (en) 2002-04-23 2003-04-22 Method for producing crystals from active ingredients in medicaments, crystals obtained by said method, and use thereof in pharmaceutical formulation

Country Status (16)

Country Link
US (1) US20030215516A1 (de)
EP (1) EP1523302A2 (de)
JP (1) JP2005535577A (de)
KR (1) KR20050003388A (de)
CN (1) CN1812767A (de)
AU (1) AU2003232490A1 (de)
BR (1) BR0309358A (de)
CA (1) CA2480130A1 (de)
DE (1) DE10218106A1 (de)
IL (1) IL163984A0 (de)
MX (1) MXPA04010466A (de)
NO (1) NO20045071L (de)
PL (1) PL371518A1 (de)
RU (1) RU2004134321A (de)
WO (1) WO2003090721A2 (de)
ZA (1) ZA200409398B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI415603B (zh) * 2005-05-20 2013-11-21 Merck Sharp & Dohme 1,8-辛二醯基苯胺羥胺酸(suberoylanilide hydroxamic acid)之調配物及其製配方法
EP1993513A4 (de) * 2006-03-14 2012-06-27 Merck Sharp & Dohme Verfahren und vorrichtung für die zubereitung von kristallinen organischen mikropartikelzusammensetzungen mittels mikromahlen und kristallisierung von mikrosamen und ihre verwendung
DE102010003711B4 (de) * 2010-04-08 2015-04-09 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoffpartikel
EP3143001B1 (de) 2014-05-13 2018-07-18 Akzo Nobel Chemicals International B.V. Verfahren zur kristallisation von chelatbildnern
CN108031142A (zh) * 2017-12-13 2018-05-15 上海合全药物研发有限公司 一种简化的利用湿磨来制备大量微晶种的装置及方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838654A (en) * 1956-02-08 1960-06-22 Upjohn Co Steroids and the production thereof
US3226389A (en) * 1962-01-04 1965-12-28 Du Pont 11,11,12,12-tetracyano-naphtho-2,6-quinodimethan and its anion-radical salts
CH627449A5 (de) * 1977-03-25 1982-01-15 Hoffmann La Roche Verfahren zur herstellung von mikrokristallinem vitamin a-acetat, sowie von trockenen, frei-fliessenden praeparaten, in welchen vitamin a-acetat in mikrokristalliner form vorliegt.
DE2801705A1 (de) * 1978-01-16 1979-07-19 Metallgesellschaft Ag Verfahren zur gewinnung von kaliumchlorid
DE3014160A1 (de) * 1979-04-16 1980-10-30 Lummus Co Kristallisationsverfahren
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
US4997637A (en) * 1989-05-09 1991-03-05 Occidental Chemical Corporation Digestive crystallizing process and apparatus for purification of KC1
FR2668945B1 (fr) * 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
DE4117717C1 (en) * 1991-05-30 1992-12-17 Dynamit Nobel Ag, 5210 Troisdorf, De Finely crystalline priming explosive prodn. - by comminuting to specified grain size in non-solvent using high speed stirrer
DE4244466C2 (de) * 1992-12-24 1995-02-23 Pharmatech Gmbh Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten

Also Published As

Publication number Publication date
MXPA04010466A (es) 2004-12-13
CA2480130A1 (en) 2003-11-06
DE10218106A1 (de) 2003-11-20
PL371518A1 (en) 2005-06-27
AU2003232490A1 (en) 2003-11-10
NO20045071L (no) 2005-01-21
KR20050003388A (ko) 2005-01-10
WO2003090721A2 (de) 2003-11-06
RU2004134321A (ru) 2005-10-10
US20030215516A1 (en) 2003-11-20
ZA200409398B (en) 2006-06-28
EP1523302A2 (de) 2005-04-20
JP2005535577A (ja) 2005-11-24
WO2003090721A3 (de) 2005-02-24
CN1812767A (zh) 2006-08-02
BR0309358A (pt) 2005-02-22

Similar Documents

Publication Publication Date Title
IL171683A (en) Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment
IL163831A (en) Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof
HUP0402588A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, process for producing them and their use
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
IL212477A0 (en) Biaryl heterocyclic compounds, methods of making the same, pharmaceutical compositions comprising them and their use in the preparation of medicaments
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
IL213597A0 (en) Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
ATE397440T1 (de) Pharmazeutische zubereitungen von antineoplastischen wirkstoffen, insbesondere temozolomid, verfahren zu ihrer herstellung und deren verwendung
IL167038A (en) Pyrazole derivatives, pharmaceutical compositions containing the same, use thereof in the manufacture of medicaments and intermediate for production thereof
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
IL195294A (en) A process for the manufacture of high purity spinamide or relapinamide, their use in the preparation of medicaments and medicinal preparations containing them
AU2002233463A1 (en) Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP1478345A4 (de) Neue pharmazeutische dosierformen und verfahren zu ihrer herstellung
HUP0303891A3 (en) Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them
PL370554A1 (en) New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
IL204947A0 (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
FR2850576B1 (fr) Composition comprenant un melange de principes actifs, et procede de preparation
IL214387A (en) History of tryptamine, method for their preparation and use for the preparation of pharmaceuticals and for the preparation of tryptamine
AU2003297199A8 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
AU2003232941A1 (en) N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them